Abstract

Human epidermal growth factor receptor type 2(HER2) affibody molecules hold the advantage of high specificity and affinity, small size, simple synthesis, and excellent biological dynamics. It has been widely used in molecular imaging and treatment of tumor, with an eye towards clinical translation. The molecular probes of radionuclide-labeled HER2 affibody can not only be used in receptor imaging and response evaluation of tumor, but also in targeted therapy. This article reviewed the latest researches on radionuclide-labeled HER2 affibody. Key words: Receptor, epidermal growth factor; Radionuclide imaging; Affibody molecules

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call